MNV
Market News Video
MNV MNV The 10 Most Popular Large-Caps in ETFs
MNV
MNV
MNV
MNV
MNV
MNV
MNV
Free Dividend Report - Top Ranked Stocks

Featured MNV Articles:

Investors Grab ADMA Even Cheaper Than Its Secondary Stock Offering
Monday, February 10, 10:23 AM ET, by Market News Video Staff

Looking back to 4 days ago, ADMA Biologics Inc (ADMA) priced a 23,500,000 share secondary ...

Top Buys by Top Brass: CEO Grossman's $300K Bet on ADMA
Tuesday, February 11, 12:16 PM ET, by Market News Video Staff

A company's own top management tend to have the best inside view into the business, ...

Look Under The Hood: IBB Has 21% Upside
Wednesday, February 19, 8:44 AM ET, by Market News Video Staff

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, ...

Analysts Predict 45% Upside For IBB
Thursday, March 26, 8:58 AM ET, by Market News Video Staff

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, ...

Analysts Forecast 27% Gains Ahead For IWO
Wednesday, April 29, 8:40 AM ET, by Market News Video Staff

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, ...

First Week of December 18th Options Trading For ADMA Biologics

By Market News Video Staff, Friday, October 16, 11:23 AM ET
Play Video: The Importance of ETFs


If the video does not load after a few moments, Upgrade to the Latest Flash Player.

Investors in ADMA Biologics Inc (NASDAQ:ADMA) saw new options begin trading this week, for the December 18th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ADMA options chain for the new December 18th contracts and identified the following call contract of particular interest.

The call contract at the $2.50 strike price has a current bid of 35 cents. If an investor was to purchase shares of ADMA stock at the current price level of $2.34/share, and then sell-to-open that call contract as a "covered call," they are committing to sell the stock at $2.50. Considering the call seller will also collect the premium, that would drive a total return (excluding dividends, if any) of 21.79% if the stock gets called away at the December 18th expiration (before broker commissions). Of course, a lot of upside could potentially be left on the table if ADMA shares really soar, which is why looking at the trailing twelve month trading history for ADMA Biologics Inc, as well as studying the business fundamentals becomes important. Below is a chart showing ADMA's trailing twelve month trading history, with the $2.50 strike highlighted in red:

Considering the fact that the $2.50 strike represents an approximate 7% premium to the current trading price of the stock (in other words it is out-of-the-money by that percentage), there is also the possibility that the covered call contract would expire worthless, in which case the investor would keep both their shares of stock and the premium collected. The current analytical data (including greeks and implied greeks) suggest the current odds of that happening are 47%. On our website under the contract detail page for this contract, Stock Options Channel will track those odds over time to see how they change and publish a chart of those numbers (the trading history of the option contract will also be charted). Should the covered call contract expire worthless, the premium would represent a 14.96% boost of extra return to the investor, or 86.60% annualized, which we refer to as the YieldBoost.

The implied volatility in the call contract example above is 145%.

Meanwhile, we calculate the actual trailing twelve month volatility (considering the last 252 trading day closing values as well as today's price of $2.34) to be 103%. For more put and call options contract ideas worth looking at, visit StockOptionsChannel.com.


This Article's Word Cloud:   ADMA   Arial   Below   Biologics   Calls   Channel   Considering   December   Investors   Options   Stock   YieldBoost   also   call   chart   contract   covered   current   expiration   expire   fillColor   greeks   history   implied   investor   left   looking   month   odds   options   premium   price   return   sell   shares   stock   strike   that   they   this   those   trading   trailing   twelve   volatility   well   which   will   worthless   would
MNV
MNV
About Us - Advertise - Contact Us - Embedding Videos - Licensing Videos - Partners - mRSS / RSS Feed - Terms of Use - Privacy Policy
MNV
Home  |  Analyst News  Dividend Report  ETFs  Insider Report  Large Caps  Market Movers  Week Ahead Report  Weekly Market Wrap
MNV
MNV MNV Chart Zero Stock Market Game Stock Market Definitions
MNV

First Week of December 18th Options Trading For ADMA Biologics | Market News Video | Copyright © 2008 - 2021, All Rights Reserved

Any ideas and opinions presented in all Market News Video clips are for informational and educational purposes only, and do not reflect the opinions of BNK Invest, Inc. or any of its affiliates, subsidiaries or partners. In no way should any content contained herein be interpreted to represent trading or investment advice. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. Read Full Disclaimer.